← Back to Search

Text Messaging for Lung Cancer

N/A

Waitlist Available

Led By David Adler, MD

Research Sponsored by University of Rochester

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 150 days

Awards & highlights

Study Summary

This trial is testing a text-based intervention to get people to get screened for lung cancer. It is a 2-year study with 366 adults from two different types of emergency departments. The goal is to see if the intervention increases the number of people who get screened for lung cancer.

Eligible Conditions

Lung Cancer

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 150 days

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~150 days

This trial's timeline: 3 weeks for screening, Varies for treatment, and 150 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Screening Uptake

Secondary outcome measures

Barriers and Perceptions about Lung Cancer Screening

Quality Indicators

Side effects data

From 2019 Phase 4 trial • 136 Patients • NCT02584140

45%

Decreased Creatinine Clearance

Abdominal Discomfort

Headache

100%

80%

60%

40%

20%

Study treatment Arm

AEGIS

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Non-adherent interventionExperimental Treatment1 Intervention

Subjects who are determined to be non-adherent to screening guidelines and are assigned to intervention treatment (text messaging) via randomization in REDCap.

Group II: Non-adherent controlActive Control1 Intervention

Subjects who are determined to be non-adherent to screening guidelines and are assigned to usual treatment via randomization in REDCap.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Text Messaging

2016

Completed Phase 4

~3950

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of RochesterLead Sponsor

840 Previous Clinical Trials

533,947 Total Patients Enrolled

David Adler, MDPrincipal InvestigatorUniversity of Rochester

1 Previous Clinical Trials

1,116 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the participant pool limited to individuals under sixty or are people of all ages eligible?

"This trial only accepts applicants aged 50 to 80. Those under 18 and over 65 have 83 and 1779 clinical trials respectively that they can take part in."

Answered by AI

Is enrolment currently available for this clinical trial?

"Affirmative. Clinicaltrials.gov hosts data that attests to the current recruitment efforts of this trial, which was made available on December 8th 2021 and amended January 4th 2022. 366 individuals from a single facility are necessary for proper completion of the study."

Answered by AI

To what extent is this experiment recruiting participants?

"Absolutely. Per clinicaltrials.gov, the research study was initially made available on December 8th 2021 and has been recently updated on January 4th 2022. The trial is actively seeking 366 patients from 1 site to participate in the experiment."

Answered by AI

Is an enrolment opportunity open for me in this experiment?

"Eligibility for this study requires applicants to be between 50 and 80 years of age with a diagnosis of the indicated emergency. In total, 366 patients are sought after by researchers."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Emergency Department Lung Cancer URMFG Pilot

David Adler 2021. "Emergency Department Lung Cancer URMFG Pilot". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04979169.